Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan I Faden

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Journal of Neurotrauma|March 1, 2006
Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injuryVilen A Movsesyan, Alan I Faden
Drug News & Perspectives|December 12, 2003
Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disordersPaul M Lea, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 5, 2010
Cell death mechanisms and modulation in traumatic brain injuryBogdan A Stoica, Alan I Faden
Trends in Pharmacological Sciences|November 2, 2010
Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategiesDavid J Loane, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 26, 2014
Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?Alan I Faden, David J Loane
International Journal of Molecular Sciences|January 22, 2014
Neuroprotective strategies for traumatic brain injury: improving clinical translationShruti V Kabadi, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Multifunctional drug treatment in neurotraumaBogdan Stoica, Kimberly Byrnes, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 5, 2011
Cell cycle activation and spinal cord injuryJunfang Wu, Bogdan A Stoica, Alan I Faden
Journal of Neurochemistry|June 11, 2004
MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factorVilen A Movsesyan, Bogdan A Stoica, Alan I Faden
British Journal of Pharmacology|April 12, 2005
Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptorsPaul M Lea, Vilen A Movsesyan, Alan I Faden
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Journal of Neurotrauma|March 1, 2006
Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injuryVilen A Movsesyan, Alan I Faden
Drug News & Perspectives|December 12, 2003
Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disordersPaul M Lea, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 5, 2010
Cell death mechanisms and modulation in traumatic brain injuryBogdan A Stoica, Alan I Faden
Trends in Pharmacological Sciences|November 2, 2010
Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategiesDavid J Loane, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 26, 2014
Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?Alan I Faden, David J Loane
International Journal of Molecular Sciences|January 22, 2014
Neuroprotective strategies for traumatic brain injury: improving clinical translationShruti V Kabadi, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Multifunctional drug treatment in neurotraumaBogdan Stoica, Kimberly Byrnes, Alan I Faden
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 5, 2011
Cell cycle activation and spinal cord injuryJunfang Wu, Bogdan A Stoica, Alan I Faden
Journal of Neurochemistry|June 11, 2004
MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factorVilen A Movsesyan, Bogdan A Stoica, Alan I Faden
British Journal of Pharmacology|April 12, 2005
Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptorsPaul M Lea, Vilen A Movsesyan, Alan I Faden
Pageof 16